679805-56-2Relevant academic research and scientific papers
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells
Carraro, Fabio,Pucci, Annalisa,Naldini, Antonella,Schenone, Silvia,Bruno, Olga,Ranise, Angelo,Bondavalli, Francesco,Brullo, Chiara,Fossa, Paola,Menozzi, Giulia,Mosti, Luisa,Manetti, Fabrizio,Botta, Maurizio
, p. 1595 - 1598 (2004)
Novel 1,4,6-trisubstituted pyrazolo[3,4-d]pyrimidines are reported with preliminary in vitro activity data indicating that several of them are potent inhibitors (better than the reference compound) of Src phosphorylation of the breast cancer cells 8701-BC
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation
Carraro, Fabio,Naldini, Antonella,Pucci, Annalisa,Locatelli, Giada A.,Maga, Giovanni,Schenone, Silvia,Bruno, Olga,Ranise, Angelo,Bondavalli, Francesco,Brullo, Chiara,Fossa, Paola,Menozzi, Giulia,Mosti, Luisa,Modugno, Michele,Tintori, Cristina,Manetti, Fabrizio,Botta, Maurizio
, p. 1549 - 1561 (2007/10/03)
We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biological properties as inhibitors of isolated Src and cell line proliferation (A431 and 8701-BC cells). Such compounds block the growth of cancer cells by interfe
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation
Schenone,Bruno,Ranise,Bondavalli,Brullo,Fossa,Mosti,Menozzi,Carraro,Naldini,Bernini,Manetti,Botta
, p. 2511 - 2517 (2007/10/03)
New 4-aminopyrazolo[3,4-d]pyrimidines bearing various substituents at the position 1 and 6, were synthesized. The new compounds showed antiproliferative activity toward A431 cells, were found to be inhibitors of Src phosphorylation, and induced apoptotic
4-SUBSTITUTED DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE AND PYRROLO[2,3-d]PYRIMIDINE AND USES THEREOF
-
Page 9, (2008/06/13)
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine are described. Compounds are active as antitumoural agents.
